Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H,- 15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy

Inorganic Chemistry

Volumn 42, Issue 18, 2003, Pages 5498-5506

  Oehlsen, Michael E ^a   Qu, Yun ^a   Farrell, Nicholas ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BBR 3005; BBR 3464; BBR 3537; BBR 3571; CISPLATIN; DNA; GLUTATHIONE; PLATINUM; PLATINUM DERIVATIVE; SODIUM CHLORIDE; SPERMIDINE; SULFUR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DNA ADDUCT; DNA DRUG COMPLEX; DRUG BIOAVAILABILITY; EXTRACELLULAR MATRIX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUTATHIONE; INDICATORS AND REAGENTS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOPLATINUM COMPOUNDS; OXIDATION-REDUCTION; QUALITY CONTROL; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0042877164     PISSN: 00201669     EISSN: None     Source Type: Journal    
DOI: 10.1021/ic030045b     Document Type: Article

References (55)

1. In Cisplatin Chemistry and Biochemistry of a Leading Anticancer Drug; Lippert, B., Ed.; Wiley-VCH: Weinheim, New York, Chichester, Brisbane, Singapore, Toronto, 1999.
2. In Platinum-Based Drugs in Cancer Therapy; Kelland, L. R., Farrell, N. F., Eds.; JAI Press: Greenwich, CT, 1996.
3. Jamieson, E. R.; Lippard, S. J. Chem. Rev. 1999, 99, 2467-2498.
4. Wong, E.; Giandomenico, C. M. Chem. Rev. 1999, 99, 2451-2466.
5. Safirstein, R.; Winston, J.; Guttenplan, J. In Biochemical Mechanisms of Platinum Antitumor Drugs; McBrien, S. C. H., Slater, T. F., Eds.; IRL Press Ltd.: Oxford, 1986; pp 271-306.
6. Farrell, N. In Advances in DNA Sequence Specific Agents; Hurley, J. H., Chaires, J. B., Eds.; JAI Press Inc.: Greenwich, CT, 1996; Vol. 2, pp 187-216.
7. Cox, J. W.; Berners-Price, S. J.; Davies, M. S.; Barklage, W.; Qu, Y.; Farrell, N. J. Am. Chem. Soc. 2001, 123, 1316-1326.
8. Farrell, N. In Platinum-Based Drugs in Cancer Therapy; Kelland, L. R., Farrell, N., Eds.; Humana Press: Totowa, NJ, 2000; pp 321-338.
9. Calvert, P. M.; Highley, M. S.; Hughes, A. N.; Plummer, E. R., Azzabi, A. S. T.; Verrill, M. W.; Camboni, M. G.; Verdi, E.; Bernareggi, E.; Zucchetti, M.; Robinson, A. M.; Carmichael, J.; Calvert, A. H. Clin. Cancer Res. 1999, 5, 3796.
10. Sessa, C.; Capri, G.; Gianni, L.; Peccatori, F.; Grasselli, G.; Bauer, J.; Zucchetti, M.; Vigano, L.; Gatti, A.; Minoia, C.; Liati, S.; Van den Bosch, S.; Bernareggi, A.; Camboni, M. G.; Marsoni, S. Anal. Oncol. 2000, 11, 977-983.
11. Roberts, J. D.; Peroutka, J.; Farrell, N. J. Inorg. Biochem. 1999, 77, 51-57.
12. Calvert, A. H.; Thomas, H.; Colombo, N.; Gore, M.; Earl, H.; Sena, L.; Camboni, G.; Liati, P.; Sessa, C. European Conference on Cancer Research; 2001.
13. Scagliotti, G. L.; Crino, L.; De Marinis, F.; Tonato, M.; Selvaggi, G.; Massoni, F.; Maestri, A.; Gatti, A.; Camboni, G. European Conference on Clionical Oncology; 2001.
14. Lempers, E. L. M.; Inagaki, K.; Reedijk, J. Inorg. Chim. Acta 1988, 152, 201-207.
15. Reedijk, J. Chem. Rev. 1999, 99, 2499-2510.
16. Kosower, N. S.; Kosower, E. M. Int. Rev. Oncol. 1978, 54, 109-156.
17. Bassolo, F.; Pearson, R. G. Mechanisms of Inorganic Reactions; New York, 1967.
18. Bonse, S.; Richards, J. M.; Ross, S. A.; Lowe, G.; Krauth-Siegel, R. L. J. Med. Chem. 2000, 43, 4812-4821.
19. Becker, K.; Herold-Mende, C.; Park, J. J.; Lowe, G.; Schirmer, R. H. J. Med. Chem. 2001, 44, 2784-2792.
20. Ivanov, A. I.; Christodoulou, J.; Parkinson, J. A.; Barnham, K. J.; Tucker, A.; Woodrow, J.; Sadler, P. J. J. Biol. Chem. 1998, 273, 14721-14730.
21. Berners-Price, S. J.; Kuchel, P. W. J. Inorg. Biochem. 1990, 38, 327-345.
22. Berners-Price, S. J.; Kuchel, P. W. J. Inorg. Biochem. 1990, 38, 305-326.
23. Appleton, T. G.; Connor, J. W.; Hall, J. R.; Prenzler, P. D. Inorg. Chem. 1989, 28, 2030-2037.
24. Djuran, I. M.; Lempers, E. L. M.; Reedijk, J. Inorg. Chem. 1991, 30, 2648-2652.
25. Mitchell, K. A.; Jensen, C. M. Inorg. Chem. 1995, 34, 4441-4446.
26. del Sucorro Murdoch, P.; Kratochwil, N. A.; Parkinson, J. A.; Patriarca, M.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, 38, 2949-2951.
27. Eastman, A.; Richon, V. M. In Biochemical Mechanisms of the Platinum Antitumor Drugs; McBrien, S. C. H., Slater, T. F., Eds.; IRL Press Limited: Oxford, 1986; pp 91-119.
28. Chen, Y.; Parkinson, J. A.; Guo, Z.; Brown, T.; Sadler, P. J. Angew. Chem., Int. Ed. 1999, 38, 2060-2063.
29. Chen, Y.; Guo, Z.; Parsons, S.; Sadler, P. J. Chem.-Eur. J. 1998, 4, 672-676.
30. Holford, J.; Sharp, S. Y.; Murrer, B. A.; Abrams, M.; Kelland, L. R. Br. J. Cancer 1198, 77, 366-373.
31. Holford, J.; Raynaud, F. I.; Murrer, B. A.; Grimaldi, K.; Hartley, J. A. ; Abrams, M.; Kelland, L. R. Anti-Cancer Drug Des. 1998, 13, 1-18.
32. Raynaud, F. I.; Boxall, F. E.; Goddard, P. M.; Valente, M.; Jones, M.; Murrer, B. A.; Abrams, M.; Kelland, L. R. Clin. Cancer Res. 1997, 3, 2063-2074.
33. Bancroft, D. P.; Lepre, C. A.; Lippard, S. J. J. Am. Chem. Soc. 1990, 112, 6860-6871.
34. Micetich, K.; Zwelling, L. A.; Kohn, K. W. Cancer Res. 1983, 43, 3609.
35. Eastman, A. Chem.-Biol. Interact. 1987, 61, 241-248.
36. Jansen, B. A.; Brouwer, J.; Reedijk, J. J. Inorg. Biochem. 2002, 89, 197-202.
37. Farrell, N.; Qu, Y.; Kasparkova, J. K.; Brabec, V.; Valsecchi, M.; Menta, E.; Di domenico, R. D. R. G. L.; Spinelli, S. Proc. Am. Assoc. Cancer Res. 1997, 38, 22077.
38. Rauter, H.; Di Domenica, R.; Menta, E.; Oliva, A.; Qu, Y.; Farrell, N. Inorg. Chem. 1994, 32, 9307-9313.
39. Kay, L. E.; Keifer, P.; Saarinen, T. J. Am. Chem. Soc. 1992, 114, 10663-10665.
40. Shaka, A. J.; Keeler, J.; Frenkiel, T.; Freeman, R. J. Magn. Reson. 1983, 52, 335.
41. Flora, J. W.; Null, A. P.; Muddiman, D. C. Anal. Biochem. 2002, 373, 538-546.
42. Flora, J. W.; Hannis, J. C.; Muddiman, D. C. Anal. Chem. 2001, 73, 1247-1251.
43. Hannis, J. C.; Muddiman, D. C. J. Am. Soc. Mass Spectrom. 2000, 11, 876-883.
44. Qu, Y.; Farrell, N. Inorg. Chem. 1992, 31, 930-932,
45. Manzotti, C.; Torriani, D.; Randisi, E.; De Georgi, M.; Pezzoni, G.; Menta, E.; Spinelli, S.; Fiebig, H. H.; Farrell, N.; Guiliani, F. C. Proc. Am. Assoc. Cancel Res. 1997, 38, 22080.
46. Davies, M. S.; Thomas, D. S.; Hegmans, A.; Berners-Price, S. J.; Farrell, N. Inorg. Chem. 2002, 41, 1101-1109.
47. Volckova, E.; Dudones, L. P.; Bose, R. N. Pharm. Res. 2002, 19, 124-130.
48. Reedijk, J.; J., F.-S. A. M.; van Oosterom, A. T.; van de Putte, P. Struct. Bonding (Berlin) 1987, 67, 53.
49. Heeg, M. J.; Elder, R. C.; Deutsch, E. Inorg. Chem. 1976, 18, 2036.
50. Adzlami, I. K.; Nosco, D. L.; Deutsch, E. J. Inorg. Nucl. Chem. 1980, 42, 1364.
51. Godwin, A. K.; Meister, A.; O'Dwyer, P. J.; Huang, C. S.; Hamilton, T. C.; Anderson, M. E. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 3070-3074.
52. Kasparkova, J.; Zehnulova, J.; Farrell, N.; Brabec, V. J. Biol. Chem., in press.
53. Zehnulova, J.; Kasparkova, J.; Farrell, N.; Brabec, V. J. Biol. Inorg. Chem. 2001, 276, 22191-22199.
54. Hegmans, A.; Qu, Y.; Kelland, L.; Roberts, J.; Farrell, N. Inorg. Chem. 2001, 40, 6108-6114.
55. Brabec, V.; Kasparkova, J.; Vrana, O.; Novakova, O.; Cox, J. W.; Qu, Y.; Farrell, N. Biochemistry 1999, 38, 6781-6790.